Association between Fecal Calprotectin and Mucosal Healing in Pediatric Patients with Crohn’s Disease Who Have Achieved Sustained Clinical Remission with Anti-Tumor Necrosis Factor Agents

Background/Aims: Although mucosal healing (MH) is acknowledged as the treatment target in the treat-to-target era, there are limitations on repeated endoscopic examinations, especially in pediatric patients. We aimed to investigate whether fecal calprotectin (FC) could serve as a surrogate marker fo...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yoo Min Lee, Sujin Choi, Byung-Ho Choe, Hyo-Jeong Jang, Seung Kim, Hong Koh, Eun Sil Kim, Mi Jin Kim, Yon Ho Choe, Ben Kang
Format:	Artigo
Idioma:	Inglês
Publicat:	Gastroenterology Council for Gut and Liver 2022-01-01
Col·lecció:	Gut and Liver
Matèries:	crohn disease infliximab adalimumab child adolescent
Accés en línia:	http://gutnliver.org/journal/view.html?doi=10.5009/gnl20300
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!